Clinical Trial Update: Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

A clinical trial is evaluating the impact of the Accu-Chek SmartGuide continuous glucose monitoring system on time-in-range compared with self-monitoring in peo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Accu-Chek SmartGuide CGM Solution

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | NA | Status: RECRUITING